Choroidal Melanoma

Authors

  • Inês Coutinho Serviço de Oftalmologia. Hospital Fernando Fonseca. Amadora. Portugal.
  • Tânia Teixeira Serviço de Radioncologia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
  • Paulo César Simões Serviço de Radioterapia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal. Unidade de Biofísica. Faculdade de Medicina. Universidade de Coimbra. Coimbra. Portugal.
  • João Casalta Lopes Serviço de Radioncologia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
  • Margarida Borrego Serviço de Radioncologia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
  • Júlia Fernandes Serviço de Oftalmologia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
  • João Cabral Serviço de Oftalmologia. Hospital da Luz. Lisboa. Portugal.
  • Isabel Prieto Serviço de Oftalmologia. Hospital Fernando Fonseca. Amadora. Portugal.
  • Rui Proença Serviço de Oftalmologia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.

DOI:

https://doi.org/10.20344/amp.8535

Keywords:

Choroid Neoplasms, Melanoma

Abstract

Choroidal melanoma is the most common primary intraocular malignant tumor in adults. None of the different treatments available offers advantages of survival, resorting more and more to conservative treatments such as brachytherapy, which has been available in Portugal since 2013. In this article we review the clinical characteristics, risk factors, diagnosis, complementary exams and therapeutic options in choroidal melanoma.

Downloads

Download data is not yet available.

Downloads

Published

2017-08-31

How to Cite

1.
Coutinho I, Teixeira T, Simões PC, Lopes JC, Borrego M, Fernandes J, Cabral J, Prieto I, Proença R. Choroidal Melanoma. Acta Med Port [Internet]. 2017 Aug. 31 [cited 2024 Apr. 20];30(7-8):573-7. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/8535

Issue

Vol. 30 No. 7-8 (2017): July-August

Section

Review Articles

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC